- NVO has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $54.0 million.
- NVO traded 501,804 shares today in the pre-market hours as of 9:01 AM, representing 40.5% of its average daily volume.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NVO with the Ticky from Trade-Ideas. See the FREE profile for NVO NOW at Trade-Ideas More details on NVO: Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The stock currently has a dividend yield of 1.4%. Currently there are 2 analysts that rate Novo Nordisk A/S a buy, 1 analyst rates it a sell, and 1 rates it a hold. The average volume for Novo Nordisk A/S has been 1.5 million shares per day over the past 30 days. Novo Nordisk A/S has a market cap of $119.0 billion and is part of the health care sector and drugs industry. Shares are up 17.9% year-to-date as of the close of trading on Wednesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.